➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
McKesson
Medtronic
Express Scripts
Merck
AstraZeneca

Last Updated: July 6, 2020

DrugPatentWatch Database Preview

Innogenix Company Profile


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for INNOGENIX, and what generic and branded alternatives to INNOGENIX drugs are available?

INNOGENIX has five approved drugs.



Summary for Innogenix
US Patents:0
Tradenames:5
Ingredients:5
NDAs:5

Drugs and US Patents for Innogenix

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Innogenix PROPRANOLOL HYDROCHLORIDE propranolol hydrochloride TABLET;ORAL 070322-002 Oct 22, 1985 AB RX No No   Start Trial   Start Trial
Innogenix HALOPERIDOL haloperidol TABLET;ORAL 071173-005 Jan 7, 1988 AB RX No No   Start Trial   Start Trial
Innogenix LABETALOL HYDROCHLORIDE labetalol hydrochloride TABLET;ORAL 075215-001 Jul 29, 1999 AB RX No No   Start Trial   Start Trial
Innogenix PROPRANOLOL HYDROCHLORIDE propranolol hydrochloride TABLET;ORAL 070322-003 Oct 22, 1985 AB RX No No   Start Trial   Start Trial
Innogenix METRONIDAZOLE metronidazole TABLET;ORAL 070772-001 Jul 16, 1986 AB RX No No   Start Trial   Start Trial
Innogenix METRONIDAZOLE metronidazole TABLET;ORAL 070772-002 Jul 16, 1986 AB RX No No   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
McKinsey
Express Scripts
Baxter
Harvard Business School
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.